{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T23:50:25Z","timestamp":1789775425438,"version":"4.0.1"},"reference-count":59,"publisher":"Elsevier BV","issue":"5-6","license":[{"start":{"date-parts":[[2004,1,1]],"date-time":"2004-01-01T00:00:00Z","timestamp":1072915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2004,1]]},"DOI":"10.1016\/j.vaccine.2003.08.036","type":"journal-article","created":{"date-parts":[[2003,10,11]],"date-time":"2003-10-11T04:49:49Z","timestamp":1065847789000},"page":"660-669","source":"Crossref","is-referenced-by-count":31,"title":["DNA Immunization of mice with a plasmid encoding Neisseria gonorrhea PorB protein by intramuscular injection and epidermal particle bombardment"],"prefix":"10.1016","volume":"22","author":[{"given":"W.","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.E.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.F.","family":"Sparling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2003.08.036_BIB1","unstructured":"WHO. Gonorrhoea estimates, 1999. Global prevalence and incidence of selected curable sexually transmitted infections. Geneva: World Health Organization; 2001. Available via http:\/\/www.emro.who.int\/ASD\/backgrounddocuments\/uae03\/surv\/stdoverview.pdf"},{"key":"10.1016\/j.vaccine.2003.08.036_BIB2","unstructured":"Hook EW, Handsfield HH. Gonococcal infections in the adult. In: Holmes KK, Mardh PA, Sparling PF, et al., editors. Sexually transmitted diseases. New York: McGraw-Hill; 1999. p. 451\u201372."},{"key":"10.1016\/j.vaccine.2003.08.036_BIB3","unstructured":"Westrom L, Eschenbach D. Pelvic inflammatory disease. In: Holmes KK, Mardh PA, Sparling PF, et al., editors. Sexually transmitted diseases. New York: McGraw-Hill; 1999. p. 783\u2013809."},{"issue":"23","key":"10.1016\/j.vaccine.2003.08.036_BIB4","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1001\/jama.1983.03340230057031","article-title":"Risk of acquiring gonorrhea and prevalence of abnormal adnexal findings among women recently exposed to gonorrhea","volume":"250","author":"Platt","year":"1983","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.vaccine.2003.08.036_BIB5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/sti.75.1.3","article-title":"From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection","volume":"75","author":"Fleming","year":"1999","journal-title":"Sex. Transm. Infect."},{"issue":"11","key":"10.1016\/j.vaccine.2003.08.036_BIB6","doi-asserted-by":"crossref","first-page":"3184","DOI":"10.1128\/AAC.44.11.3184-3185.2000","article-title":"Antimicrobial resistance of Neisseria gonorrhoeae and emerging ciprofloxacin resistance in The Netherlands, 1991 to 1998","volume":"44","author":"de Neeling","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2","key":"10.1016\/j.vaccine.2003.08.036_BIB7","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1128\/JCM.38.2.521-525.2000","article-title":"Antimicrobial resistance of Neisseria gonorrhoeae and high prevalence of ciprofloxacin-resistant isolates in Japan, 1993 to 1998","volume":"38","author":"Tanaka","year":"2000","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.vaccine.2003.08.036_BIB8","doi-asserted-by":"crossref","unstructured":"Sparling PF, Thomas CE, Zhu W. A vaccine for gonorrhea. In: Ellis RW, Brodeur BR, editors. Bacterial vaccines. Georgetown, TX: Landes Bioscience; 2003. p. 127\u201353.","DOI":"10.1007\/978-1-4615-0053-7_9"},{"key":"10.1016\/j.vaccine.2003.08.036_BIB9","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0140-6736(01)32510-2","article-title":"The treatment of gonococcus infections by vaccines","volume":"174","author":"Eyre","year":"1909","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.vaccine.2003.08.036_BIB10","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/infdis\/133.4.441","article-title":"Immunity in infection with Neisseria gonorrhoeae: duration and serological response in the chimpanzee","volume":"133","author":"Arko","year":"1976","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.vaccine.2003.08.036_BIB11","first-page":"29","article-title":"Gonococcal vaccine studies in Inuvik","volume":"65","author":"Greenberg","year":"1974","journal-title":"Can. J. Public Health"},{"issue":"1","key":"10.1016\/j.vaccine.2003.08.036_BIB12","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1093\/infdis\/163.1.128","article-title":"Human immunization with Pgh 3-2 gonococcal pilus results in cross-reactive antibody to the cyanogen bromide fragment-2 of pilin","volume":"163","author":"Johnson","year":"1991","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.vaccine.2003.08.036_BIB13","unstructured":"Brinton Jr. CC, Wood SW, Brown A, et al. The development of a neisserial pilus vaccine for gonorrhea and meningococcal meningitis. In: Robbins JB, Hill CM, Sadoff JC, editors. Bacterial vaccines. New York: Thieme\u2013Stratton Inc.; 1982. p. 140\u201359."},{"issue":"3","key":"10.1016\/j.vaccine.2003.08.036_BIB14","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/0264-410X(91)90147-X","article-title":"Efficacy trial of a parenteral gonococcal pilus vaccine in men","volume":"9","author":"Boslego","year":"1991","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2003.08.036_BIB15","doi-asserted-by":"crossref","first-page":"5699","DOI":"10.1128\/IAI.67.11.5699-5708.1999","article-title":"Experimental gonococcal genital tract infection and opacity protein expression in estradiol-treated mice","volume":"67","author":"Jerse","year":"1999","journal-title":"Infect. Immun."},{"issue":"3","key":"10.1016\/j.vaccine.2003.08.036_BIB16","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1086\/315801","article-title":"Intranasal immunization with gonococcal outer membrane preparations reduces the duration of vaginal colonization of mice by Neisseria gonorrhoeae","volume":"182","author":"Plante","year":"2000","journal-title":"J. Infect. Dis."},{"issue":"8","key":"10.1016\/j.vaccine.2003.08.036_BIB17","first-page":"2269","article-title":"The potential protective effect of immunization with outer-membrane protein I from Neisseria gonorrhoeae","volume":"135","author":"Heckels","year":"1989","journal-title":"J. Gen. Microbiol."},{"issue":"6","key":"10.1016\/j.vaccine.2003.08.036_BIB18","first-page":"1621","article-title":"Monoclonal antibodies to gonococcal outer membrane protein IB: use in investigation of the potential protective effect of antibodies directed against conserved and type-specific epitopes","volume":"132","author":"Virji","year":"1986","journal-title":"J. Gen. Microbiol."},{"issue":"11","key":"10.1016\/j.vaccine.2003.08.036_BIB19","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1099\/00221287-139-11-2613","article-title":"Structural comparison and epitope analysis of outer-membrane protein PIA from strains of Neisseria gonorrhoeae with differing serovar specificities","volume":"139","author":"Mee","year":"1993","journal-title":"J. Gen. Microbiol."},{"issue":"11","key":"10.1016\/j.vaccine.2003.08.036_BIB20","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1099\/00221287-136-11-2165","article-title":"Gonococcal outer-membrane protein PIB: comparative sequence analysis and localization of epitopes which are recognized by type-specific and cross-reacting monoclonal antibodies","volume":"136","author":"Butt","year":"1990","journal-title":"J. Gen. Microbiol."},{"issue":"3","key":"10.1016\/j.vaccine.2003.08.036_BIB21","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1093\/infdis\/166.3.551","article-title":"Gonococcal porin vaccine evaluation: comparison of Por proteosomes, liposomes, and blebs isolated from rmp deletion mutants","volume":"166","author":"Wetzler","year":"1992","journal-title":"J. Infect. Dis."},{"issue":"5","key":"10.1016\/j.vaccine.2003.08.036_BIB22","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1093\/infdis\/152.5.990","article-title":"Antibody-antigen specificity in the immune response to infection with Neisseria gonorrhoeae","volume":"152","author":"Lammel","year":"1985","journal-title":"J. Infect. Dis."},{"issue":"5","key":"10.1016\/j.vaccine.2003.08.036_BIB23","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1172\/JCI114040","article-title":"Epidemiologic evidence for the development of serovar-specific immunity after gonococcal infection","volume":"83","author":"Plummer","year":"1989","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.vaccine.2003.08.036_BIB24","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/oxfordjournals.aje.a009820","article-title":"Longitudinal evaluation of serovar-specific immunity to Neisseria gonorrhoeae","volume":"149","author":"Fox","year":"1999","journal-title":"Am. J. Epidemiol."},{"issue":"12","key":"10.1016\/j.vaccine.2003.08.036_BIB25","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0966-842X(00)89012-5","article-title":"Vaccines for gonorrhea: where are we on the curve?","volume":"3","author":"Blake","year":"1995","journal-title":"Trends Microbiol."},{"issue":"5","key":"10.1016\/j.vaccine.2003.08.036_BIB26","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1084\/jem.164.5.1735","article-title":"Immunoglobulin G antibodies directed against protein III block killing of serum-resistant Neisseria gonorrhoeae by immune serum","volume":"164","author":"Rice","year":"1986","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.vaccine.2003.08.036_BIB27","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1146\/annurev.immunol.15.1.617","article-title":"DNA vaccines","volume":"15","author":"Donnelly","year":"1997","journal-title":"Annu. Rev. Immunol."},{"issue":"5102","key":"10.1016\/j.vaccine.2003.08.036_BIB28","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1126\/science.8456302","article-title":"Heterologous protection against influenza by injection of DNA encoding a viral protein","volume":"259","author":"Ulmer","year":"1993","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.vaccine.2003.08.036_BIB29","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1128\/IAI.32.2.641-648.1981","article-title":"Monoclonal antibodies against Neisseria gonorrhoeae: production of antibodies directed against a strain-specific cell surface antigen","volume":"32","author":"Nachamkin","year":"1981","journal-title":"Infect. Immun."},{"issue":"3","key":"10.1016\/j.vaccine.2003.08.036_BIB30","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1093\/infdis\/169.3.532","article-title":"Human experimentation with Neisseria gonorrhoeae: rationale, methods, and implications for the biology of infection and vaccine development","volume":"169","author":"Cohen","year":"1994","journal-title":"J. Infect. Dis."},{"issue":"9","key":"10.1016\/j.vaccine.2003.08.036_BIB31","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1089\/dna.1993.12.777","article-title":"Heterologous and homologous protection against influenza A by DNA vaccination: optimization of DNA vectors","volume":"12","author":"Montgomery","year":"1993","journal-title":"DNA Cell Biol."},{"issue":"7","key":"10.1016\/j.vaccine.2003.08.036_BIB32","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/BF02780975","article-title":"Characterization of a subunit structure and stability of the recombinant porin from Neisseria gonorrhoeae","volume":"17","author":"Matsuka","year":"1998","journal-title":"J. Protein Chem."},{"issue":"2","key":"10.1016\/j.vaccine.2003.08.036_BIB33","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1006\/viro.1997.8878","article-title":"Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo","volume":"239","author":"Pushko","year":"1997","journal-title":"Virology"},{"issue":"5","key":"10.1016\/j.vaccine.2003.08.036_BIB34","doi-asserted-by":"crossref","first-page":"3411","DOI":"10.4049\/jimmunol.134.5.3411","article-title":"Monoclonal antibodies directed against gonococcal protein I vary in bactericidal activity","volume":"134","author":"Joiner","year":"1985","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.vaccine.2003.08.036_BIB35","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1128\/IAI.58.4.1078-1084.1990","article-title":"Monoclonal antibodies to outer membrane protein PII block interactions of Neisseria gonorrhoeae with human neutrophils","volume":"58","author":"Elkins","year":"1990","journal-title":"Infect. Immun."},{"issue":"1","key":"10.1016\/j.vaccine.2003.08.036_BIB36","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1128\/IAI.50.1.116-122.1985","article-title":"Stimulation of human leukocytes by protein II+ gonococci is mediated by lectin-like gonococcal components","volume":"50","author":"Rest","year":"1985","journal-title":"Infect. Immun."},{"issue":"6","key":"10.1016\/j.vaccine.2003.08.036_BIB37","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1128\/IAI.56.6.1574-1579.1988","article-title":"Gonococci possessing only certain P.II outer membrane proteins interact with human neutrophils","volume":"56","author":"Fischer","year":"1988","journal-title":"Infect. Immun."},{"issue":"18","key":"10.1016\/j.vaccine.2003.08.036_BIB38","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1111\/j.1365-2958.1992.tb01439.x","article-title":"Antibodies to N-terminal peptides of gonococcal porin are bactericidal when gonococcal lipopolysaccharide is not sialylated","volume":"6","author":"Elkins","year":"1992","journal-title":"Mol. Microbiol."},{"issue":"3","key":"10.1016\/j.vaccine.2003.08.036_BIB39","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S1567-5769(00)00037-0","article-title":"C4bp binding to porin mediates stable serum resistance of Neisseria gonorrhoeae","volume":"1","author":"Ram","year":"2001","journal-title":"Int. Immunopharmacol."},{"issue":"4","key":"10.1016\/j.vaccine.2003.08.036_BIB40","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/1520-6017(200104)90:4<474::AID-JPS1005>3.0.CO;2-6","article-title":"Antigen levels and antibody titers after DNA vaccination","volume":"90","author":"Chastain","year":"2001","journal-title":"J. Pharm. Sci."},{"issue":"8","key":"10.1016\/j.vaccine.2003.08.036_BIB41","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/S0264-410X(96)00265-4","article-title":"Biological features of genetic immunization","volume":"15","author":"Barry","year":"1997","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2003.08.036_BIB42","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0167-5699(97)01201-2","article-title":"Gene vaccination: plasmid DNA is more than just a blueprint","volume":"19","author":"Tighe","year":"1998","journal-title":"Immunol. Today"},{"issue":"3","key":"10.1016\/j.vaccine.2003.08.036_BIB43","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1128\/CMR.8.3.406","article-title":"Nucleic acid vaccines","volume":"8","author":"Vogel","year":"1995","journal-title":"Clin. Microbiol. Rev."},{"issue":"5","key":"10.1016\/j.vaccine.2003.08.036_BIB44","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1006\/smim.1997.0083","article-title":"DNA vaccines","volume":"9","author":"Robinson","year":"1997","journal-title":"Semin. Immunol."},{"issue":"2","key":"10.1016\/j.vaccine.2003.08.036_BIB45","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1046\/j.1365-2249.1997.4411339.x","article-title":"Comparison of nucleic acid and protein immunization for induction of antibodies specific for HIV-1 gp120","volume":"109","author":"Peet","year":"1997","journal-title":"Clin. Exp. Immunol."},{"issue":"1","key":"10.1016\/j.vaccine.2003.08.036_BIB46","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1046\/j.1365-2249.1999.00941.x","article-title":"DNA vaccination favours memory rather than effector B cell responses","volume":"117","author":"Laylor","year":"1999","journal-title":"Clin. Exp. Immunol."},{"issue":"11\u201312","key":"10.1016\/j.vaccine.2003.08.036_BIB47","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1016\/S0264-410X(01)00498-4","article-title":"Immunogenicity of the Brucella melitensis recombinant ribosome recycling factor-homologous protein and its cDNA","volume":"20","author":"Cassataro","year":"2002","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2003.08.036_BIB48","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0264-410X(97)00147-3","article-title":"Epitope specificity of antibodies raised against enterotoxigenic Escherichia coli CFA\/I fimbriae in mice immunized with naked DNA","volume":"16","author":"Alves","year":"1998","journal-title":"Vaccine"},{"issue":"26","key":"10.1016\/j.vaccine.2003.08.036_BIB49","doi-asserted-by":"crossref","first-page":"14626","DOI":"10.1073\/pnas.94.26.14626","article-title":"DNA immunization: induction of higher avidity antibody and effect of route on T cell cytotoxicity","volume":"94","author":"Boyle","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"8","key":"10.1016\/j.vaccine.2003.08.036_BIB50","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1086\/339677","article-title":"Immune protection against staphylococcal enterotoxin-induced toxic shock by vaccination with a Venezuelan equine encephalitis virus replicon","volume":"185","author":"Lee","year":"2002","journal-title":"J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.vaccine.2003.08.036_BIB51","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1600-0897.1999.tb00466.x","article-title":"Mucosal immunity in the genital tract: prospects for vaccines against sexually transmitted diseases\u2014a review","volume":"42","author":"Russell","year":"1999","journal-title":"Am. J. Reprod. Immunol."},{"issue":"3","key":"10.1016\/j.vaccine.2003.08.036_BIB52","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/ni769","article-title":"Neisserial binding to CEACAM1 arrests the activation and proliferation of CD4+ T lymphocytes","volume":"3","author":"Boulton","year":"2002","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.vaccine.2003.08.036_BIB53","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0264-410X(98)00151-0","article-title":"CpG motifs as immune adjuvants","volume":"17","author":"Klinman","year":"1999","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2003.08.036_BIB54","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1073\/pnas.93.7.2879","article-title":"CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma","volume":"93","author":"Klinman","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"6522","key":"10.1016\/j.vaccine.2003.08.036_BIB55","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/374546a0","article-title":"CpG motifs in bacterial DNA trigger direct B-cell activation","volume":"374","author":"Krieg","year":"1995","journal-title":"Nature"},{"issue":"5273","key":"10.1016\/j.vaccine.2003.08.036_BIB56","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1126\/science.273.5273.352","article-title":"Immunostimulatory DNA sequences necessary for effective intradermal gene immunization","volume":"273","author":"Sato","year":"1996","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.vaccine.2003.08.036_BIB57","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1006\/viro.1996.0603","article-title":"Immunization with plasmid DNA encoding for the measles virus hemagglutinin and nucleoprotein leads to humoral and cell-mediated immunity","volume":"225","author":"Cardoso","year":"1996","journal-title":"Virology"},{"issue":"8","key":"10.1016\/j.vaccine.2003.08.036_BIB58","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S0264-410X(96)00279-4","article-title":"Polynucleotide vaccines in animals: enhancing and modulating responses","volume":"15","author":"Lewis","year":"1997","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2003.08.036_BIB59","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1111\/j.1365-2958.1990.tb00673.x","article-title":"Construction of isogenic gonococci with variable porin structure: effects on susceptibility to human serum and antibiotics","volume":"4","author":"Carbonetti","year":"1990","journal-title":"Mol. Microbiol."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X03006479?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X03006479?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T03:33:34Z","timestamp":1682566414000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X03006479"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1]]},"references-count":59,"journal-issue":{"issue":"5-6","published-print":{"date-parts":[[2004,1]]}},"alternative-id":["S0264410X03006479"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2003.08.036","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2004,1]]}}}